Embed Size (px)
Citation preview
September�20�to�21,�2018,�Laupheim,�Germany
Biotech Days5th Laupheim
Pre-Announcement5th Laupheim Biotech Days
Bioprocess Intensification
Pre-Announcement4th Laupheim Biotech Days
Fusion Proteins – deliveringnovel therapeutic options
Biotech Days4th
Laupheim
June 13 to 14, 2016, Laupheim, Germany
Pre-Announcement-A5-4Seiter_v8.indd 1 16.11.15 13:51
2 3
Event HighlightsThis�conference�examines�the�state�of�the�art�in�all�aspects�of�upstream�and�downstream�bioprocess�intensifi�cation,�including�the�integration�of�continuous�operation�modes�and�shedding�light�on�the�immense�opportunities�presented�through�technical�solutions,�while�critically�discussing�the�limits�of�these�approaches.�We�will�start�with�an�introductory�session�particularly�for�students�and�a�keynote�lecture�by�Michael�Scholl,�CEO�Leukocare�AG,�in�the�pleasant�atmosphere�at�the�historic�castle�Großlaupheim.
TopicsThe�program�covers�major�trends�in�continuous�upstream�and�downstream�processing,�novel�approaches�to�process�analytics,�the�evaluation�of�economic�benefi�ts�and�the�expectations�of�regulatory�authorities.�A�wide�range�of�internationally�renowned�scientists�and�researchers�will�deliver�a�comprehensive�overview�on�the�state�of�the�art,�combining�critical�reviews�with�detailed�case�studies.�
Facility TourAt�the�fi�rst�conference�day�you�have�the�opportunity�to�participate�at�a�tour�ofRentschler�Biopharma’s�Facility.
Young Scientists Cell Culture Biotechnology RetreatA�cell�culture�meeting�is�held�as�a�pre-conference�before�the�offi�cial�start�of�the�Biotech�Days.�PhD�students�are�invited�to�present�their�scientifi�c�work�related�to�the�intensifi�cation�of�cell�culture-based�bioprocesses.�The�retreat�is�free�for�all�attendees.
The�intensifi�cation�of�bioprocesses�has�raised�attention�because�of�the�growing�demand�for�economical�and�sustainable�process�designs.�Improvements�can�be�made�by�increasing�titer�and�volumetric�productivity,�reducing�processing�time�and�process�scale,�facilitating�downstream�operations,�and�simplifying�thetechnology�transfer.�New�high-end�upstream�and�downstreamoperations�ensure�the�next�generation�of�reliable�bioprocesses�based�on�robust�cell�lines�with�product�quality�safeguards.�Despite�the�obvious�advantages,�such�as�higher�productivity�with�a�smaller�facility�footprint,�lower�capital�expenditures�and�consistent�product�quality,�there�are�still�issues�to�be�solved.�For�instance,�online�monitoring�of�process�parameters�and�product�quality�is�still�a�challenge.�However,�due�to�the�availability�of�disposable�equipment�for�all�process�steps,�the�entry�hurdles�have�been�signifi�cantly�lowered�over�the�last�years.�This�make�it�worthwhile�to�take�a�closer�look�at�these�exciting�process�intensifi�cation�technologies.
We are looking forward to welcoming you in Laupheim!
Dr.�Ralf�OttoChief�Operating�Offi�cer
Prof.�Dr.�Roland�Wagner�Senior�Advisor�
3
ContactIf�you�have�any�questions�about�the�conference,�accommodations,�venue�or�travel,�please�contact:�Petra�König,�Rentschler�Biopharma�SE,�[email protected]
For�information�please�visit�www.biotech-days.com.
Confirmed speakers•��Prof.�Dr.�Nicole�Borth•��Prof.�Dr.�Florian�Wurm•��Dr.�Veronique�Chotteau•��Prof.�Dr.�Udo�Reichl•��Prof.�Dr.�Jürgen�Hubbuch•��Prof.�Dr.�Alois�Jungbauer
VenueSchloss�Großlaupheim,�Claus-Graf-Stauffenberg-Straße�15,�88471�Laupheim,�Germany.�
AccommodationAccommodation�will�be�organized�for�the�speakers.
Biotech Days5th Laupheim
Bioprocess Intensification
Passion for Performance
Rentschler Biopharma SE Erwin-Rentschler-Str.�21�·�88471�Laupheim�·�[email protected]�·�www.rentschler-biopharma.com
A world-class biopharmaceutical CDMO
Our partnerships
•���Experts�in�cell�culture�bioprocess�development�and�manufacturing
•���Family-owned�company,�globally�thinkingand�focused�exclusively�on�our�clients‘�projects
•���Biopharma�pioneer�with�commitment�for�technology�and�innovation�leadership
•����Extensive�track�record,�40�years�of�experience�and�made�in�Germany
Strategic�Alliance�with
Best-in-class�formulations�provide�signifi�cant�
competitive�advantages
Strategic�Partnership�with
Complete�solutions�with�state-of-the-art�fi�ll�and�
fi�nish�facilites
